MBX Biosciences, Inc.
Pharmaceutical company · Carmel, Indiana, United States · Nasdaq: MBX
MBX Biosciences, Inc. is a pharmaceutical company headquartered in Carmel, Indiana, United States. Its earliest recorded incorporation is in 2019. Its shares trade on Nasdaq under the ticker MBX. It has reported private securities offerings to the US SEC, most recently $47 million sold in a notice filed in 2022.
MBX Biosciences at a glance
What does MBX Biosciences do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $46.7 million sold (2022).
Frequently asked questions about MBX Biosciences
Where is MBX Biosciences headquartered?
MBX Biosciences, Inc. is headquartered in Carmel, Indiana, United States.
What does MBX Biosciences do?
MBX Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is MBX Biosciences a public company?
Yes. MBX Biosciences, Inc. trades on Nasdaq under the ticker MBX.
When was MBX Biosciences founded?
The earliest incorporation on record for MBX Biosciences, Inc. is in 2019, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.